Telix Pharmaceuticals Ltd Adr (TLX)

Feb 21, 2025

Telix Pharmaceuticals Ltd (TLPPF) (FY 2024) Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada

Feb 21, 2025

Feb 20, 2025

Can Telix's Triple Product Launch in 2025 Justify Its Bold $1.2B Revenue Target? - StockTitan

Feb 20, 2025

Feb 13, 2025

Clinical Trial Success: Telix's Revolutionary Prostate Cancer Treatment Shows Promising Results - StockTitan

Feb 13, 2025

Feb 12, 2025

Major Breakthrough: Revolutionary Prostate Cancer Detection Tool Gets UK Green Light - StockTitan

Feb 12, 2025

Jan 30, 2025

Telix Pharmaceuticals acquires ImaginAb assets and technology - Investing.com

Jan 30, 2025

Jan 30, 2025

Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform - GlobeNewswire Inc.

Jan 30, 2025

Jan 13, 2025

Telix Pharmaceuticals Hits Record $517M Revenue, Up 55% as Cancer Imaging Portfolio Expands - StockTitan

Jan 13, 2025

Jan 12, 2025

Telix Pharmaceuticals Acquires ImaginAb's Cancer Drug Pipeline in $45M Strategic Deal - StockTitan

Jan 12, 2025

Jan 08, 2025

ASX December health sector winners… and a 91pc drop for a trial-flopped stock - Stockhead

Jan 08, 2025

Dec 31, 2024

ASX healthcare 2024 winners and losers, plus what’s next for 2025 - Stockhead

Dec 31, 2024

Nov 27, 2024

Health Check: ASX sleep company emerges from slumber with a revenue and earnings upgrade - Stockhead

Nov 27, 2024

Nov 15, 2024

UBS bullish on Telix stock—Illuccix growth & therapeutic expansion fuel upside - Investing.com

Nov 15, 2024

Nov 13, 2024

TLXTelix Pharmaceuticals Ltd ADR Latest Stock News & Market Updates - StockTitan

Nov 13, 2024

Nov 13, 2024

Telix Pharmaceuticals Debuts on Nasdaq Global Select Market Under TLX Symbol - StockTitan

Nov 13, 2024

Oct 22, 2024

Telix spins off radiopharma unit to form Rhine Pharma | Pharmaceutical | The Pharmaletter - The Pharma Letter

Oct 22, 2024

Oct 18, 2024

Guess which top 100 ASX stock is venturing off to the Nasdaq - The Motley Fool Australia

Oct 18, 2024

Oct 17, 2024

Telix Files Form 20-F Registration Statement for Nasdaq ADS - GlobeNewswire

Oct 17, 2024

Jul 16, 2024

Up 66% in FY24, will Telix Pharmaceuticals shares continue? - The Motley Fool Australia

Jul 16, 2024

Jun 14, 2024

TLX ASX: Telix pulls $300m Nasdaq IPO as investors demand deep discount - The Australian Financial Review

Jun 14, 2024

Jan 31, 2024

Pharmaceutical Industry Mergers & Acquisitions Roundup - Contract Pharma

Jan 31, 2024

Jan 05, 2024

Australia's Telix Pharmaceuticals jumps on potential US listing - Reuters.com

Jan 05, 2024

Nov 03, 2022

Check Up: These 4 ASX healthcare stocks come with Strong Buy recommendations - Stockhead

Nov 03, 2022

Mar 01, 2016

Queen's University Leads Irish Trial of New Prostate Cancer Treatment - Imaging Technology News

Mar 01, 2016